Coronary intervention in patients with acute coronary syndrome: Does every culprit lesion require revascularization?

Current Cardiology Reports

Volumn 12, Issue 4, 2010, Pages 330-337

  Bangalore, Sripal ^a   Faxon, David P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute coronary syndromes; Complete revascularization; Culprit lesion angioplasty

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON; CORONARY ARTERY BYPASS; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX;

EID: 77956392119     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0115-8     Document Type: Review

References (32)

1. American Heart Association: Heart Disease and Stroke Statistics - 2009 Update. Dallas, TX: American Heart Association; 2009.
2. Kushner FG, Hand M, Smith SC Jr, et al.: 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, 120:2271-2306.
3. Abbott JD, Ahmed HN, Vlachos HA, et al.: Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2007, 100:190-195.
4. Goldstein JA, Demetriou D, Grines CL, et al.: Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000, 343:915-922.
5. Jaski BE, Cohen JD, Trausch J, et al.: Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: Comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 1992, 124:1427-1433.
6. Kahn JK, Rutherford BD, McConahay DR, et al.: Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. J Am Coll Cardiol 1990, 16:1089-1096.
7. Muller DW, Topol EJ, Ellis SG, et al.: Multivessel coronary artery disease: A key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J 1991, 121(4 Pt 1):1042-1049.
8. Anderson JL, Adams CD, Antman EM, et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007, 116:e148-e304.
9. Wu X, Maehara A, Mintz GS, et al.: Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes. Am J Cardiol 105:48-53.
10. Corpus RA, House JA, Marso SP, et al.: Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004, 148:493-500.
11. Grines CL, Topol EJ, Califf RM, et al.: Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. Circulation 1989, 80:245-253.
12. Gibson CM, Ryan KA, Murphy SA, et al.: Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1999, 34:974-982.
13. Bell MR, Gersh BJ, Schaff HV, et al.: Effect of completeness of revascularization on long-term outcome of patients with threevessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation 1992, 86:446-457.
14. Jones EL, Weintraub WS: The importance of completeness of revascularization during long-term follow-up after coronary artery operations. J Thorac Cardiovasc Surg 1996, 112:227-237.
15. Scott R, Blackstone EH, McCarthy PM, et al.: Isolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary artery: Late consequences of incomplete revascularization. J Thorac Cardiovasc Surg 2000, 120:173-184.
16. Vander Salm TJ, Kip KE, Jones RH, et al.: What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2002, 39:565-572
17. Bourassa MG, Kip KE, Jacobs AK, et al.: Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999, 33:1627-1636.
18. Ochala A, Smolka GA, Wojakowski W, et al.: The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction. J Invasive Cardiol 2004, 16:699-702.
19. Di Mario C, Mara S, Flavio A, et al.: Single vs multivessel treatment during primary angioplasty: Results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent 2004, 6:128-133.
20. Politi L, Sgura F, Rossi R, et al. Multivessel coronary disease in ST-elevation myocardial infarction: Three different revascularization strategies and long-term outcomes. Heart 2009 Sep 23 [Epub ahead of print]. This trial of 214 consecutive patients with STEMI and MVD randomized patients into three groups: Culprit vessel angioplasty only, staged revascularization, or simultaneous treatment of non-IRAs. The study showed that culprit vessel only angioplasty was associated with the highest rate of long-term MACE
21. Brener SJ, Milford-Beland S, Roe MT, et al.: Culprit-only or multivessel revascularization in patients with acute coronary syndromes: An American College of Cardiology National Cardiovascular Database Registry report. Am Heart J 2008, 155:140-146. Using the ACC/NCDR database, 72,048 patients with ACS and multivessel coronary artery disease with a singlevessel PCI were compared to 33,818 patients with multivessel PCI. After adjustment, procedural success was greater for single-vessel PCI but MACE was similar
22. Roe MT, Cura FA, Joski PS, et al.: Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol 2001, 88:170-173, A6
23. Rigattieri S, Biondi-Zoccai G, Silvestri P, et al.: Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty. J Interv Cardiol, 2008 21(1): 1-7.
24. Khattab AA, Abdel-Wahab M, Rother C, et al.: Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol 2008, 97:32-38.
25. Kong JA, Chou ET, Minutello RM, et al.: Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: Report from the New York State Angioplasty Registry. Coron Artery Dis 2006, 17:71-75.
26. Qarawani D, Nahir M, Abboud M, et al.: Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol 2008, 123:288-292.
27. Seo J: Long-term outcomes of culprit only versus complete coronary revascularization during primary percutaneous coronary intervention. J Am Coll Cardiol 2009, 53(Suppl 1):2512.
28. Hannan EL, Samadashvili Z, Walford G, et al.: Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010, 3:22-31. Using the NY State PCI reporting system, 3521 patients underwent culprit lesion angioplasty with 259 having a staged PCI during the hospital admission and 538 having a staged PCI within 60 days. The in-hospital mortality was lower for culprit vessel PCI only but staged multivessel PCI within 60 days had a significantly lower 12-month mortality rate supporting the ACC/AHA guideline recommendations
29. Bangalore S, Sawhney S, Kinlay S, Faxon D: Complete revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A meta-analysis. Circulation 2009, 120(Suppl):S987. This meta-analysis included 15 studies with more than 9000 patients. A strategy of complete revascularization was associated with a 47% reduction in mortality as well as need for CABG or repeat PCI. Long-term MACE was reduced by 43%.
30. Brener SJ, Murphy SA, Gibson CM, et al.: Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes. Am J Cardiol 2002, 90:631-633.
31. Shishehbor MH, Lauer MS, Singh IM, et al.: In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culpritonly stenting? J Am Coll Cardiol 2007, 49:849-854. This observational study from the Cleveland Clinic evaluated culpritonly stenting versus multivessel stenting in 1240 patients with ACS and MVD. Multivessel stents were associated with lower death, MI, or revascularization at an average of 2.3 years of follow-up after adjustment and propensity matching.
32. Zapata GO, Lasave LI, Kozak F, et al.: Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: One-year follow-up. J Interv Cardiol 2009, 22:329-335.